A pulse rapamycin therapy for infantile spasms and associated cognitive decline

This publication has 61 references indexed in Scilit:

• Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
  Neurobiology of Disease, 2010
• Modeling new therapies for infantile spasms
  Epilepsia, 2010
• The natural history of epilepsy in tuberous sclerosis complex
  Epilepsia, 2010
• A model of symptomatic infantile spasms syndrome
  Neurobiology of Disease, 2010
• Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies
  Epilepsia, 2009
• From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis
  Journal of Intellectual Disability Research, 2009
• Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
  Nature Medicine, 2008
• Cell‐specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers
  Annals of Neurology, 2008
• Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
  New England Journal of Medicine, 2008
• Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons
  Epilepsy Research, 2007